{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:21:16Z","timestamp":1693326076205},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ejphar.2008.01.021","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T13:44:33Z","timestamp":1202305473000},"page":"166-174","source":"Crossref","is-referenced-by-count":18,"title":["A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors"],"prefix":"10.1016","volume":"584","author":[{"given":"Ben S.","family":"Zweifel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medora M.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn R.","family":"Dufield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Pufahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime L.","family":"Masferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.01.021_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0091-6749(98)70054-5","article-title":"A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast asthma study group","volume":"102","author":"Altman","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/rccm.200208-802OC","article-title":"A randomized controlled trial of intravenous montelukast in acute asthma","volume":"167","author":"Camargo","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2008.01.021_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.173.1.624","article-title":"Rac and protein kinase C-{delta} regulate ERKs and cytosolic phospholipase A2 in Fc{epsilon}RI signaling to cysteinyl leukotriene synthesis in mast cells","volume":"173","author":"Cho","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib4","doi-asserted-by":"crossref","first-page":"40376","DOI":"10.1074\/jbc.M401294200","article-title":"Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-Oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells","volume":"279","author":"Erlemann","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0006-2952(93)90185-Y","article-title":"Criteria for the identification of non-redox inhibitors of 5-lipoxygenase","volume":"45","author":"Falgueyret","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bjp.0705860","article-title":"Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610","volume":"142","author":"Fischer","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1096\/fj.02-0815fje","article-title":"Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.01.021_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1074\/jbc.M506513200","article-title":"Arachidonic acid regulates the translocation of 5-Lipoxygenase to the nuclear membranes in human neutrophils","volume":"281","author":"Flamand","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjp.0705654","article-title":"Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP","volume":"141","author":"Flamand","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1165\/ajrcmb.21.1.3517","article-title":"5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils","volume":"21","author":"Guilbert","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib11","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1073\/pnas.80.14.4349","article-title":"Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils","volume":"80","author":"Ham","year":"1983","journal-title":"PNAS"},{"key":"10.1016\/j.ejphar.2008.01.021_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.275.12.931","article-title":"Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton clinical trial group","volume":"275","author":"Israel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2008.01.021_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-6749(96)80002-9","article-title":"Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial Zileuton study group","volume":"98","author":"Liu","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/jm950363n","article-title":"Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-Lipoxygenase","volume":"39","author":"Malamas","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib15","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1016\/S0021-9258(18)53486-4","article-title":"Reversible translocation of 5-lipoxygenase in mast cells upon IgE\/antigen stimulation","volume":"268","author":"Malaviya","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib16","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.ejphar.2008.01.021_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaci.2004.04.015","article-title":"The mastocyte: the \u201cother\u201d inflammatory cell in immunopathogenesis","volume":"114","author":"Mekori","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0960-894X(00)00370-X","article-title":"5-HETE congeners as modulators of cell proliferation","volume":"10","author":"Miller","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2008.01.021_bib19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0091-6749(03)01888-8","article-title":"5-Oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin","volume":"112","author":"Muro","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.plipres.2005.04.002","article-title":"Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE","volume":"44","author":"Powell","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2008.01.021_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ab.2007.02.009","article-title":"Development of a fluorescence-based enzyme assay of human 5-lipoxygenase","volume":"364","author":"Pufahl","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"4819","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2008.01.021_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinte.158.2.141","article-title":"A randomized controlled trial comparing zileuton with theophylline in moderate asthma","volume":"158","author":"Schwartz","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2008.01.021_bib24","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1172\/JCI1995","article-title":"5-Oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in brown norway rats","volume":"102","author":"Stamatiou","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.01.021_bib25","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.171.11.6119","article-title":"Fc{epsilon}RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals","volume":"171","author":"Suzuki","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib26","doi-asserted-by":"crossref","first-page":"48751","DOI":"10.1074\/jbc.M409738200","article-title":"Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide","volume":"279","author":"Swindle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.021_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","article-title":"Therapeutic options for 5-lipoxygenase inhibitors","volume":"112","author":"Werz","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.01.021_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/mol.54.2.445","article-title":"Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity","volume":"54","author":"Werz","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0005-2760(96)00074-4","article-title":"Arachidonate-induced eicosanoid synthesis in RBL-2H3 cells: stimulation with antigen or A23187 induces prolonged activation of 5-lipoxygenase","volume":"1303","author":"Westcott","year":"1996","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.ejphar.2008.01.021_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mai.2000.106485","article-title":"The diverse potential effector and immunoregulatory roles of mast cells in allergic disease","volume":"105","author":"Williams","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.01.021_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.0954-7894.2002.01263.x","article-title":"Blockade of superoxide generation prevents high-affinity immunoglobulin E receptor-mediated release of allergic mediators by rat mast cell line and human basophils","volume":"32","author":"Yoshimaru","year":"2002","journal-title":"Clin. Exp. Allergy."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T13:01:46Z","timestamp":1630674106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014299908000885"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.01.021","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}